4//SEC Filing
Molineaux Christopher P. 4
Accession 0001209191-23-039080
CIK 0001557746other
Filed
Jun 21, 8:00 PM ET
Accepted
Jun 22, 4:32 PM ET
Size
7.0 KB
Accession
0001209191-23-039080
Insider Transaction Report
Form 4
Molineaux Christopher P.
Director
Transactions
- Exercise/Conversion
Common Stock
2023-06-20$1.41/sh+16,500$23,265→ 48,503 total - Exercise/Conversion
Stock Option (right to buy)
2023-06-20−16,500→ 0 totalExercise: $1.41Exp: 2030-06-03→ Common Stock (16,500 underlying)
Footnotes (1)
- [F1]The shares underlying this option vested in twelve equal monthly installments commencing July 4, 2020, subject to the reporting person's continued service with the Issuer as of the applicable vesting date.
Documents
Issuer
Aclaris Therapeutics, Inc.
CIK 0001557746
Entity typeother
Related Parties
1- filerCIK 0001654773
Filing Metadata
- Form type
- 4
- Filed
- Jun 21, 8:00 PM ET
- Accepted
- Jun 22, 4:32 PM ET
- Size
- 7.0 KB